Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study

Purpose Breast cancer patients with treatment-induced menopause experience frequent and severe hot flashes (HF). We compared venlafaxine and clonidine for the treatment of HF with regard to side effects, efficacy, quality of life and sexual functioning. Methods In a double-blind, cross-over study, 6...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2009-06, Vol.115 (3), p.573-580
Hauptverfasser:	Buijs, Ciska, Mom, Constantijne H, Willemse, Pax H. B, Marike Boezen, H, Maurer, J. Marina, Wymenga, A. N. Machteld, de Jong, Robert S, Nieboer, Peter, de Vries, Elisabeth G. E, Mourits, Marian J. E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenergic alpha-Agonists - therapeutic use Adult Biological and medical sciences Breast cancer Breast Neoplasms - complications Cancer research Cancer therapies Clinical Trial Clinical trials Clonidine - therapeutic use Cross-Over Studies Cyclohexanols - therapeutic use Dermatology Double-Blind Method Drug therapy Female Gynecology. Andrology. Obstetrics Hot Flashes - drug therapy Humans Mammary gland diseases Medical sciences Medicine Medicine & Public Health Menopause Middle Aged Oncology Quality of Life Serotonin Uptake Inhibitors - therapeutic use Sexual Behavior Side effects Skin involvement in other diseases. Miscellaneous. General aspects Treatment Outcome Tumors Vascular disorders of the skin Venlafaxine Hydrochloride
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!